Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „ADRs“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), unc
Eintrag öffnenAbilify Maintena · 4.8 · All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), unc
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbilify Maintena · 4.8 · The incidences of the ADRs associated with Abilify Maintena 400 mg/300 mg and 960 mg/720 mg are tabulated belo
Eintrag öffnenAbilify Maintena · 4.8 · The incidences of the ADRs associated with aripiprazole therapy are tabulated below. The table is based on adv
Eintrag öffnenAbilify Maintena · 4.8 · The most frequently observed ADRs reported in ≥ 5 % of patients in two double-blind, long-term trial of Abilif
Eintrag öffnenAbilify Maintena · 4.8 · The most frequently observed adverse drug reactions (ADRs) reported in ≥ 5 % of patients in two double-blind,
Eintrag öffnenAdvate · 4.8 · ADRs specific to residues from the manufacturing process
Eintrag öffnenAdvate · 4.8 · ADRs specific to residues from the manufacturing process
Eintrag öffnenAjovy · 4.8 · ADRs from clinical studies and post-marketing reports are presented according to MedDRA system organ classific
Eintrag öffnenAjovy · 4.8 · Commonly reported adverse drug reactions (ADRs) were local reactions at the injection site (pain [24%], indura
Eintrag öffnenAjovy · 4.8 · The following ADRs have been identified for AJOVY (Table 1).
Eintrag öffnenAldurazyme · 4.8 · Paediatric population ADRs to Aldurazyme reported during a Phase 2 study in a total of 20 patients, under 5 ye
Eintrag öffnenAldurazyme · 4.8 · Tabulated list of adverse reactions ADRs to Aldurazyme reported during the Phase 3 study and its extension in
Eintrag öffnenAlecensa · 4.8 · 9 System organ class Alecensa ADRs (MedDRA) N = 533 Frequency category Frequency category (all grades) (grades
Eintrag öffnenAlecensa · 4.8 · Table 3 ADRs reported in Alecensa clinical trials (BO40336, BO28984, NP28761, NP28673; N = 533) System organ c
Eintrag öffnenAlecensa · 4.8 · Tabulated list of adverse drug reactions Table 3 lists the ADRs occurring in patients who received Alecensa ac
Eintrag öffnenAlecensa · 4.8 · The ADRs listed in Table 3 are presented by system organ class and frequency categories, defined using the fol
Eintrag öffnenAlimta · 4.8 · ADRs are listed by MedDRA body system organ class. The following convention has been used for classification o
Eintrag öffnen